Olmesartan medoximil en es it fr

Olmesartan medoximil Brand names, Olmesartan medoximil Analogs

Olmesartan medoximil Brand Names Mixture

  • No information avaliable

Olmesartan medoximil Chemical_Formula

C29H30N6O6

Olmesartan medoximil RX_link

http://www.rxlist.com/cgi/generic/benicar.htm

Olmesartan medoximil fda sheet

Olmesartan_medoximil FDA

Olmesartan medoximil msds (material safety sheet)

Olmesartan_medoximil MSDS

Olmesartan medoximil Synthesis Reference

No information avaliable

Olmesartan medoximil Molecular Weight

558.585 g/mol

Olmesartan medoximil Melting Point

175-180 oC

Olmesartan medoximil H2O Solubility

No information avaliable

Olmesartan medoximil State

Solid

Olmesartan medoximil LogP

5.202

Olmesartan medoximil Dosage Forms

Tablet

Olmesartan medoximil Indication

For the treatment of hypertension

Olmesartan medoximil Pharmacology

Olmesartan Medoxomil, a specific angiotensin II type 1 antagonist, is used alone or with other antihypertensive agents to treat hypertension. Unlike the angiotensin receptor antagonist losartan, olmesartan does not have an active metabolite or possess uricosuric effects. Blockade of the angiotensin II receptor inhibits the negative regulatory feedback of angiotensin II on renin secretion, but the resulting increased plasma renin activity and circulating angiotensin II levels do not overcome the effect of olmesartan on blood pressure.

Olmesartan medoximil Absorption

Bioavailability is about 26%. Food does not affect the bioavailability of olmesartan.

Olmesartan medoximil side effects and Toxicity

Symptoms of overdose include dehydration (dry mouth, excessive thirst, muscle pain or cramps, nausea and vomiting, weakness), dizziness, low blood pressure, and slow or irregular heartbeat.

Olmesartan medoximil Patient Information

Olmesartan medoximil Organisms Affected

Humans and other mammals